Isometric illustration of a multi-channel coating head applying colored strips onto a moving film web to form multi-formula ODF lanes, with minimal downstream slitting.

One Film, Many Formulas: How Strip-Based Coating Turns Multi-Formula ODFs into Scalable Reality

Fixed-dose combinations (FDCs), multi-ingredient functional ODFs (for example, multivitamins, probiotic blends, or herbal combinations) are no longer just a concept. Regulators and patients increasingly expect combination therapies and convenient single-dose formats – which means more projects where one oral film needs to carry more than one formula.

However, when these projects move from R&D to GMP-scale manufacturing, every extra process step adds variability, waste and validation complexity. The real question becomes: Can we put multiple formulas on one film in a way that is stable, efficient and truly scalable?

HUANGHAI’s strip-based multi-formula coating approach, powered by patent CN117323228A , was designed to answer exactly this question.


Trend: One Film, Multiple Formulas

Market demand is shifting from simple, single-API ODFs toward:

  • Fixed-dose combinations (FDCs) that combine multiple actives in one strip.
  • Multi-ingredient functional ODFs – for example, vitamins plus probiotics, or botanicals plus minerals.
  • Segmented films where different lanes or zones carry different strengths or ingredient sets.

From a formulation point of view, many of these concepts are achievable in the lab. The bottleneck comes later: how to turn a smart bench-top idea into a repeatable, GMP-ready manufacturing process.


Pain Points in Conventional ODF Manufacturing

Traditional ODF production often follows a familiar sequence: wide-web coating → edge trimming → longitudinal slitting → cross-cutting. This works well for single-formula films, but when you try to run multiple formulas in parallel, several problems are amplified:

  • Significant material waste: High-value APIs and excipients end up in edge trims and offcuts during slitting and re-shaping.
  • Consistency risks: Multiple coating runs or secondary lamination steps can introduce dosage variation, lane-width drift and edge defects.
  • Complex validation: More steps mean more critical parameters to define and monitor, making batch-to-batch variation harder to explain during audits.

In other words, the more you rely on secondary slitting and reshaping to “create” multi-formula strips, the harder it becomes to control yield, uniformity and regulatory risk at commercial scale.

This is precisely the pain point targeted by CN117323228A: using a strip-based coating structure so that multi-formula lanes are formed directly in the coating step, instead of being carved out later.


HUANGHAI’s Answer: Strip-Based Multi-Formula Coating

HUANGHAI’s multi-formula strip coating solution is built on the patented Slitting-Type Film Coating Device (CN117323228A) . Instead of coating a full-width web and then cutting it down, the system is engineered to shape each strip at the coating stage itself.

1. Multi-Channel Feed and Structured Strip Geometry

At the heart of the system is a multi-channel feed manifold with dedicated supply grooves for each formulation. Each channel defines its own target lane on the substrate, including width and spacing.

This design allows:

  • Different formulas to run in parallel lanes on the same web.
  • Strip width to be geometrically constrained by the coating hardware, not left entirely to downstream slitting.
  • Adjustments to be made at the coating head (lane width, pattern, layout) instead of adding more post-processing steps.

2. Less Reliance on Downstream Slitting

Because the film already emerges from the coater in a structured, multi-lane layout, downstream operations can focus on simple, aligned cutting and packaging instead of heavy reshaping. This directly reduces:

  • Edge trim waste and “sacrificed” lanes.
  • Opportunities for lateral strip drift and lane-width variability.
  • The number of critical control points that must be validated and monitored.

3. Better Fit for GMP Scale-Up

By removing redundant steps from the process, the strip-based approach makes the manufacturing route:

  • Shorter: Fewer unit operations and less handling.
  • Easier to validate: Key parameters are concentrated at the coater and dryer, where they can be tightly controlled.
  • More robust: Lane width and dosage alignment are maintained by mechanical design as well as process control.

Related product

MJ150 ODF & Transdermal Patch Film Making Machine

Doctor-blade coating, 0.2–5 m/min running speed, drying from room temperature up to 120 °C.

View product page →Request a quote →

What This Means for Your ODF Project

1. Lower Material Loss

With multi-formula lanes already shaped at the coating step, you no longer “create” strip geometry by cutting away large portions of the film. This is especially important for high-value APIs and specialty excipients, where edge scrap can become a major cost driver.

2. More Stable Content and Strip Width Uniformity

When each lane is defined by hardware geometry and controlled coating parameters, it is easier to:

  • Keep strip width within tight tolerances across the full roll.
  • Preserve dosage ratios between lanes (for example, API A on the left, API B on the right).
  • Maintain a stable process window during scale-up from pilot runs to commercial campaigns.

3. Fewer Steps, Fewer Stops

A shorter, more integrated process means:

  • Fewer intermediate rewinds and re-threading operations.
  • Less time spent on cleaning and changeover between runs.
  • Validation packages that are easier to explain to regulators, with a clear chain from formulation to film to sachet.

Recommended Equipment and Configurations

HUANGHAI’s strip-based multi-formula coating technology is implemented across both pilot-scale and commercial systems, so you can maintain the same logic from development through scale-up.

MJ150-L – Pilot and Medium-Scale Multi-Formula Coating

The MJ150-L ODF Film Coating Machine is designed for pilot-scale and medium-scale ODF production. It is ideal for:

  • Establishing multi-formula coating windows and strip layouts.
  • Optimising lane widths, viscosities and drying logic under controlled conditions.
  • Preparing data and samples for registration, technology transfer and partner evaluations.

MJ150 – Commercial-Scale Multi-Formula ODF and Patch Production

For commercial output, the MJ150 ODF & Transdermal Patch Film Making Machine inherits the same core coating logic and supports high-throughput, multi-lane production. It is engineered for:

  • Pharma-grade ODF combination products.
  • Solvent-based transdermal patches using similar strip-based concepts.
  • Integration with downstream slitting and high-speed pouching lines.

For a broader view of how these systems fit into a full line, see:



*The MJ150 production line's patented hot-air drying tunnel (Academician Hou Huimin's patent CN201668734U).


Explosion-proof electrical configuration is available as an option for flammable-solvent formulations.

Conclusion: Making “One Film, Many Formulas” an Engineering Reality

The true competitiveness of multi-formula ODFs is not just about whether a formulation can be created in the lab. It comes from turning that formulation into a short, stable and verifiable manufacturing process.

HUANGHAI’s strip-based coating innovation, backed by patent CN117323228A, shifts complexity upstream into a structured coating architecture – reducing waste and process noise in the downstream steps. With MJ150-L and MJ150 working as a coherent pair, “one film, many formulas” becomes less of an experiment and more of a scalable, GMP-ready production strategy.

If you are evaluating multi-API or combination ODF projects and want to reduce risk during scale-up, our team can help design a multi-formula coating route tailored to your products and regulatory pathway.

Contact HUANGHAI to discuss how strip-based multi-formula coating can support your next ODF line.

\n

Frequently Asked Questions

What is the difference between an ODF film and a transdermal patch?
Oral dissolving films (ODF) dissolve on or under the tongue within seconds to minutes; transdermal patches stick to the skin and release the API over hours to days. Both are made by solvent-cast film coating, and the MJ Pro coating platform can be built for either — the application is set before the machine is manufactured.

What output can I expect from Huanghai ODF machines?
MJ150-RD about 1,200 films per hour for formulation screening; MJ150-Lab 8,000–10,000 films per hour for pilot-scale work; MJ150 about 30,000 films per hour (Gen I) for commercial production. For packaging, the MJ180 cuts and packs about 11,900 films per hour (Gen I); the EZ320 (about 9,000 films per hour) is for food-grade films only.

What drying technology is used?
The MJ150 production line uses a patented hot-air parallel-flow drying tunnel (Academician Hou Huimin's patent CN201668734U). The MJ150-RD uses oven drying; the MJ150-Lab uses the same hot-air drying process as the MJ150.

Can Huanghai machines coat multi-formula (striped) films?
Yes. Huanghai's patent CN117323228A covers stripe coating that applies two formulations side by side in one pass, useful for fixed-dose combination films.

Compare all ODF equipment in the ODF buying guide →

Explore Complete ODF & TDDS Manufacturing Solutions

Huanghai offers end-to-end ODF film production lines — from R&D (MJ150-RD / MJ150-Lab) to commercial manufacturing (MJ150). Designed for GMP production and to support 21 CFR Part 11 requirements.

View ODF Production Line Solutions →  |  Request a Quote

Back to blog

Contact us